Subodh Verma

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

Mikhail Kosiborod, John Deanfield, Richard Pratley et al. · The Lancet · 2024 · 264 citations

Medicine, Cardiology, Pharmacology +9

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure

Scott D. Solomon, John W. Ostrominski, Xiaowen Wang et al. · Journal of the American College of Cardiology · 2024 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

Sanjiv J Shah, Kavita Sharma, Barry A. Borlaug et al. · European Heart Journal · 2024 · 82 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12

Inflammation in Obesity-Related HFpEF

Subodh Verma, Mark C. Petrie, Barry A. Borlaug et al. · Journal of the American College of Cardiology · 2024 · 77 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial

Kausik K. Ray, Ena Oru, Robert S. Rosenson et al. · The Lancet · 2025 · 64 citations

Pharmacy, Pharmacology, Pharmacotherapy +11